0001869338-23-000001.txt : 20230712 0001869338-23-000001.hdr.sgml : 20230712 20230712161428 ACCESSION NUMBER: 0001869338-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230712 DATE AS OF CHANGE: 20230712 EFFECTIVENESS DATE: 20230712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADvantage Therapeutics, Inc. CENTRAL INDEX KEY: 0001869338 IRS NUMBER: 863737093 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-486678 FILM NUMBER: 231084360 BUSINESS ADDRESS: STREET 1: 215 N NEW RIVER DR. E 4200 CITY: FORT LAUDERDALE STATE: FL ZIP: 33301 BUSINESS PHONE: 630-886-7345 MAIL ADDRESS: STREET 1: 215 N NEW RIVER DR. E 4200 CITY: FORT LAUDERDALE STATE: FL ZIP: 33301 D 1 primary_doc.xml X0708 D LIVE 0001869338 ADvantage Therapeutics, Inc. 195 NW 40th Street MIAMI FL FLORIDA 33127 3058469027 DELAWARE None None Corporation true 2021 Agustin Fernandez Santana III 195 NW 40th Street Miami FL FLORIDA 33127 Executive Officer Director Jeffrey B. Madden 195 NW 40th Street Miami FL FLORIDA 33127 Executive Officer Director Frank Mattner 195 NW 40th Street Miami FL FLORIDA 33127 Director Walter Schmidt 195 NW 40th Street Miami FL FLORIDA 33127 Director David Buchsbaum 195 NW 40th Street Miami FL FLORIDA 33127 Executive Officer James O'Neill 195 NW 40th Street Miami FL FLORIDA 33127 Director Other Health Care Decline to Disclose 06b false 2023-06-28 false true false 0 25449956 10224998 15224958 Amounts include conversion of outstanding convertible securities. false 17 0 0 0 false ADvantage Therapeutics, Inc. David Buchsbaum David Buchsbaum Chief Financial Officer 2023-07-12